179 related articles for article (PubMed ID: 11266816)
41. Anergic T cells generated in vitro suppress rejection response to islet allografts.
Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
[TBL] [Abstract][Full Text] [Related]
42. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
43. The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection.
Dai Z; Lakkis FG
Curr Opin Immunol; 1999 Oct; 11(5):504-8. PubMed ID: 10508707
[TBL] [Abstract][Full Text] [Related]
44. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
Akalin E; Chandraker A; Russell ME; Turka LA; Hancock WW; Sayegh MH
Transplantation; 1996 Dec; 62(12):1942-5. PubMed ID: 8990393
[TBL] [Abstract][Full Text] [Related]
45. T cell tolerance in transplantation: possibilities for therapeutic intervention.
Cobbold SP
Expert Opin Ther Targets; 2002 Oct; 6(5):583-99. PubMed ID: 12387682
[TBL] [Abstract][Full Text] [Related]
46. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
47. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection.
Nadeau K; Azuma H; Chandraker A; Sayegh MH; Tilney NL
Transplant Proc; 1997; 29(1-2):1038. PubMed ID: 9123187
[No Abstract] [Full Text] [Related]
49. B7/CTLA4 pathway is essential for generating regulatory cells after intratracheal delivery of alloantigen in mice.
Akiyama Y; Shirasugi N; Uchida N; Matsumoto K; Kitajima M; Bashuda H; Yagita H; Okumura K; Aramaki O; Niimi M
Transplantation; 2002 Sep; 74(5):732-8. PubMed ID: 12352894
[TBL] [Abstract][Full Text] [Related]
50. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
[TBL] [Abstract][Full Text] [Related]
51. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
Bolling SF; Lin H; Wei RQ; Turka LA
J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
[TBL] [Abstract][Full Text] [Related]
52. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
[TBL] [Abstract][Full Text] [Related]
53. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
[TBL] [Abstract][Full Text] [Related]
54. Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis.
Schaub M; Issazadeh S; Stadlbauer TH; Peach R; Sayegh MH; Khoury SJ
J Neuroimmunol; 1999 May; 96(2):158-66. PubMed ID: 10337914
[TBL] [Abstract][Full Text] [Related]
55. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
DiPaolo RJ; Unanue ER
J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
[TBL] [Abstract][Full Text] [Related]
56. Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death.
Wekerle T; Kurtz J; Sayegh M; Ito H; Wells A; Bensinger S; Shaffer J; Turka L; Sykes M
J Immunol; 2001 Feb; 166(4):2311-6. PubMed ID: 11160287
[TBL] [Abstract][Full Text] [Related]
57. In vivo function of immune inhibitory molecule B7-H4 in alloimmune responses.
Yamaura K; Watanabe T; Boenisch O; Yeung M; Yang S; Magee CN; Padera R; Datta S; Schatton T; Kamimura Y; Azuma M; Najafian N
Am J Transplant; 2010 Oct; 10(10):2355-62. PubMed ID: 21143433
[TBL] [Abstract][Full Text] [Related]
58. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
Larsen CP; Elwood ET; Alexander DZ; Ritchie SC; Hendrix R; Tucker-Burden C; Cho HR; Aruffo A; Hollenbaugh D; Linsley PS; Winn KJ; Pearson TC
Nature; 1996 May; 381(6581):434-8. PubMed ID: 8632801
[TBL] [Abstract][Full Text] [Related]
59. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.
Reddy B; Gupta S; Chuzhin Y; Kalergis AM; Budhai L; Zhang M; Droguett G; Horwitz MS; Chowdhury JR; Nathenson SG; Davidson A
Transplantation; 2001 Mar; 71(6):801-11. PubMed ID: 11330546
[TBL] [Abstract][Full Text] [Related]
60. Addition of an IL-15 mutant/FCgamma2A antagonist protein protects islet allografts from rejection overriding costimulation blockade.
Ferrari-Lacraz S; Zheng XX; Kim YS; Maslinski W; Strom TB
Transplant Proc; 2002 May; 34(3):745-7. PubMed ID: 12034169
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
